Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss ...

CERA Deputy Director and Head of Macular Research Professor Robyn Guymer AM and CERA Head of Ophthalmic Epidemiology Research ...

Central serous retinopathy and macular degeneration both affect the retinas in your eyes, but one does not lead to the other. They share similar symptoms but have differing causes and risk factors.

Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at ...

Ireland has become the first country to recruit patients onto a new global clinical trial into a potential treatment for a ...

Opthea’s eye disease drug has failed its second phase 3 trial in a week, leaving the Australian biotech to discard the entire ...

Dr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the ...

After announcing that lead candidate sozinibercept (OPT-302) failed the phase III Coast trial in wet age-related macular degeneration (AMD), Opthea has now decided to close the Coast trial as well as ...

Spring is a time of renewal and vibrancy, but it also brings unique challenges for our eyes. As we shed the winter layers and ...

Acer Medical has recently launched its AI-assisted screening software, VeriSee Diabetic Retinopathy and VeriSee Age-Related Macular Degeneration. These innovative solutions will be showcased at the ...

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye ...

Do you know the "three C's of measles"? As measles outbreaks emerge in the U.S., it is important to know the symptoms and ...